Medhealth insight

X-twitter Linkedin Facebook
Menu

eClinical Trial Management

eClinical Trial Management

Oral Semaglutide Greatly Lowers Heart Attack & Stroke Risk in Type 2 Diabetes

Semaglutide, a glucagon-like peptide-1 receptor agonist, has gained recognition for its role in managing weight, blood sugar, and even alcohol cravings. Both its injectable and oral forms have been...

Trending News

The red tape of regulation

Insights
Many companies understand and are committed...

Advocating a trial for falls prevention...

Clinical Trial Management
Nobody would dispute that the volume...

Improving Healthcare Through Clinical Coordination Tools

Clinical Management System
Patients are usually treated by multiple...

Innovative walker with cues shows promising...

Insights
Maintaining an optimal level of physical...

How passive RFID technology can transform...

Insights
In today's fast-paced healthcare environments, hospitals...